Advertisement
Screener

ELI LILLY AND COMPANY (LLY) Earnings Per Share (Diluted)

ELI LILLY AND COMPANY Earnings Per Share (Diluted)

ELI LILLY AND COMPANY (LLY) reported Earnings Per Share (Diluted) of $7.94 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareDiluted · last filed 2026-08-05

  • ELI LILLY AND COMPANY earnings per share, diluted for the quarter ending 2026-06-30 was $7.94, a 26.23% increase year-over-year.
  • ELI LILLY AND COMPANY earnings per share, diluted for the quarter ending 2026-03-31 was $8.26, a 169.93% increase year-over-year.
  • ELI LILLY AND COMPANY earnings per share, diluted for the quarter ending 2025-12-31 was $7.39, a 51.38% increase year-over-year.
  • ELI LILLY AND COMPANY earnings per share, diluted for the quarter ending 2025-09-30 was $6.21, a 480.37% increase year-over-year.
  • ELI LILLY AND COMPANY earnings per share, diluted for fiscal 2025 was $22.95, a 95.99% increase from fiscal 2024.
  • ELI LILLY AND COMPANY earnings per share, diluted for fiscal 2024 was $11.71, a 101.90% increase from fiscal 2023.
  • ELI LILLY AND COMPANY earnings per share, diluted for fiscal 2023 was $5.80, a 15.94% decline from fiscal 2022.
  • ELI LILLY AND COMPANY earnings per share, diluted for fiscal 2022 was $6.90, a 12.75% increase from fiscal 2021.
Period endEarnings Per Share, Diluted 3 monthEarnings Per Share, Diluted 6 monthEarnings Per Share, Diluted 9 monthEarnings Per Share, Diluted 12 month
2026-06-30$7.94
10-Q · filed 2026-08-05
$16.19
10-Q · filed 2026-08-05
$23.58
derived: net income ÷ weighted average shares · filed 2026-08-05
$29.79
derived: net income ÷ weighted average shares · filed 2026-08-05
2026-03-31$8.26
10-Q · filed 2026-04-30
$15.65
derived: net income ÷ weighted average shares · filed 2026-04-30
$21.85
derived: net income ÷ weighted average shares · filed 2026-04-30
$28.14
derived: net income ÷ weighted average shares · filed 2026-08-05
2025-12-31$7.39
derived: net income ÷ weighted average shares · filed 2026-02-12
$13.60
derived: net income ÷ weighted average shares · filed 2026-02-12
$19.89
derived: net income ÷ weighted average shares · filed 2026-08-05
$22.95
10-K · filed 2026-02-12
2025-09-30$6.21
10-Q · filed 2025-10-30
$12.50
derived: net income ÷ weighted average shares · filed 2026-08-05
$15.56
10-Q · filed 2025-10-30
$20.44
derived: net income ÷ weighted average shares · filed 2026-08-05
2025-06-30$6.29
10-Q · filed 2026-08-05
$9.35
10-Q · filed 2026-08-05
$14.24
derived: net income ÷ weighted average shares · filed 2026-08-05
$15.30
derived: net income ÷ weighted average shares · filed 2026-08-05
2025-03-31$3.06
10-Q · filed 2026-04-30
$7.95
derived: net income ÷ weighted average shares · filed 2026-04-30
$9.01
derived: net income ÷ weighted average shares · filed 2026-04-30
$12.30
derived: net income ÷ weighted average shares · filed 2026-04-30
2024-12-31$4.88
derived: net income ÷ weighted average shares · filed 2026-02-12
$5.95
derived: net income ÷ weighted average shares · filed 2026-02-12
$9.23
derived: net income ÷ weighted average shares · filed 2026-02-12
$11.71
10-K · filed 2026-02-12
2024-09-30$1.07
10-Q · filed 2025-10-30
$4.35
derived: net income ÷ weighted average shares · filed 2025-10-30
$6.83
10-Q · filed 2025-10-30
$9.26
derived: net income ÷ weighted average shares · filed 2026-02-12
2024-06-30$3.28
10-Q · filed 2025-08-07
$5.76
10-Q · filed 2025-08-07
$8.19
derived: net income ÷ weighted average shares · filed 2026-02-12
$8.13
derived: net income ÷ weighted average shares · filed 2026-02-12
2024-03-31$2.48
10-Q · filed 2025-05-01
$4.90
derived: net income ÷ weighted average shares · filed 2026-02-12
$4.85
derived: net income ÷ weighted average shares · filed 2026-02-12
$6.80
derived: net income ÷ weighted average shares · filed 2026-02-12
2023-12-31$2.42
derived: net income ÷ weighted average shares · filed 2026-02-12
$2.36
derived: net income ÷ weighted average shares · filed 2026-02-12
$4.32
derived: net income ÷ weighted average shares · filed 2026-02-12
$5.80
10-K · filed 2026-02-12
2023-09-30-$0.06
10-Q · filed 2024-10-30
$1.89
derived: net income ÷ weighted average shares · filed 2024-10-30
$3.38
10-Q · filed 2024-10-30
$5.53
derived: net income ÷ weighted average shares · filed 2025-02-19
2023-06-30$1.95
10-Q · filed 2024-08-08
$3.44
10-Q · filed 2024-08-08
$5.58
derived: net income ÷ weighted average shares · filed 2025-02-19
$7.19
derived: net income ÷ weighted average shares · filed 2025-02-19
2023-03-31$1.49
10-Q · filed 2024-04-30
$3.63
derived: net income ÷ weighted average shares · filed 2025-02-19
$5.24
derived: net income ÷ weighted average shares · filed 2025-02-19
$6.29
derived: net income ÷ weighted average shares · filed 2025-02-19
2022-12-31$2.14
derived: net income ÷ weighted average shares · filed 2025-02-19
$3.75
derived: net income ÷ weighted average shares · filed 2025-02-19
$4.80
derived: net income ÷ weighted average shares · filed 2025-02-19
$6.90
10-K · filed 2025-02-19
2022-09-30$1.61
10-Q · filed 2023-11-02
$2.66
derived: net income ÷ weighted average shares · filed 2023-11-02
$4.76
10-Q · filed 2023-11-02
$6.66
derived: net income ÷ weighted average shares · filed 2024-02-21
2022-06-30$1.05
10-Q · filed 2023-08-08
$3.16
10-Q · filed 2023-08-08
$5.05
derived: net income ÷ weighted average shares · filed 2024-02-21
$6.27
derived: net income ÷ weighted average shares · filed 2024-02-21
2022-03-31$2.10
10-Q · filed 2023-04-27
$3.99
derived: net income ÷ weighted average shares · filed 2024-02-21
$5.21
derived: net income ÷ weighted average shares · filed 2024-02-21
$6.74
derived: net income ÷ weighted average shares · filed 2024-02-21
2021-12-31$1.89
derived: net income ÷ weighted average shares · filed 2024-02-21
$3.11
derived: net income ÷ weighted average shares · filed 2024-02-21
$4.64
derived: net income ÷ weighted average shares · filed 2024-02-21
$6.12
10-K · filed 2024-02-21
2021-09-30$1.22
10-Q · filed 2022-11-01
$2.75
derived: net income ÷ weighted average shares · filed 2022-11-01
$4.23
10-Q · filed 2022-11-01
$6.55
derived: net income ÷ weighted average shares · filed 2023-02-22
2021-06-30$1.53
10-Q · filed 2022-08-04
$3.01
10-Q · filed 2022-08-04
$5.33
derived: net income ÷ weighted average shares · filed 2023-02-22
$6.66
derived: net income ÷ weighted average shares · filed 2023-02-22
2021-03-31$1.49
10-Q · filed 2022-04-29
$3.80
derived: net income ÷ weighted average shares · filed 2023-02-22
$5.13
derived: net income ÷ weighted average shares · filed 2023-02-22
$6.68
derived: net income ÷ weighted average shares · filed 2023-02-22
2020-12-31$2.32
derived: net income ÷ weighted average shares · filed 2023-02-22
$3.64
derived: net income ÷ weighted average shares · filed 2023-02-22
$5.19
derived: net income ÷ weighted average shares · filed 2023-02-22
$6.79
10-K · filed 2023-02-22
2020-09-30$1.33
10-Q · filed 2021-10-27
$2.88
derived: net income ÷ weighted average shares · filed 2021-10-27
$4.47
10-Q · filed 2021-10-27
$6.11
derived: net income ÷ weighted average shares · filed 2022-02-23
2020-06-30$1.55
10-Q · filed 2021-08-03
$3.15
10-Q · filed 2021-08-03
$4.78
derived: net income ÷ weighted average shares · filed 2022-02-23
$6.15
derived: net income ÷ weighted average shares · filed 2022-02-23
2020-03-31$1.60
10-Q · filed 2021-04-30
$3.23
derived: net income ÷ weighted average shares · filed 2022-02-23
$4.60
derived: net income ÷ weighted average shares · filed 2022-02-23
$6.03
derived: net income ÷ weighted average shares · filed 2022-02-23
2019-12-31$1.64
10-K · filed 2020-02-19
$3.00
derived: net income ÷ weighted average shares · filed 2022-02-23
$4.43
derived: net income ÷ weighted average shares · filed 2022-02-23
$8.89
10-K · filed 2022-02-23
2019-09-30$1.37
10-Q · filed 2020-10-28
$2.80
derived: net income ÷ weighted average shares · filed 2020-10-28
$7.24
10-Q · filed 2020-10-28
$8.26
derived: net income ÷ weighted average shares · filed 2021-02-17
2019-06-30$1.44
10-Q · filed 2020-07-31
$5.84
10-Q · filed 2020-07-31
$6.85
derived: net income ÷ weighted average shares · filed 2021-02-17
$7.93
derived: net income ÷ weighted average shares · filed 2021-02-17
2019-03-31$4.31
10-Q · filed 2020-05-01
$5.35
derived: net income ÷ weighted average shares · filed 2021-02-17
$6.45
derived: net income ÷ weighted average shares · filed 2021-02-17
$6.16
derived: net income ÷ weighted average shares · filed 2021-02-17
2018-12-31$1.10
10-K · filed 2020-02-19
$2.22
derived: net income ÷ weighted average shares · filed 2021-02-17
$1.96
derived: net income ÷ weighted average shares · filed 2021-02-17
$3.13
10-K · filed 2021-02-17
2018-09-30$1.12
10-K · filed 2020-02-19
$0.87
derived: net income ÷ weighted average shares · filed 2019-10-25
$2.03
10-Q · filed 2019-10-25
$0.43
derived: net income ÷ weighted average shares · filed 2020-02-19
2018-06-30-$0.25
10-K · filed 2020-02-19
$0.92
10-Q · filed 2019-08-02
-$0.67
derived: net income ÷ weighted average shares · filed 2020-02-19
-$0.14
derived: net income ÷ weighted average shares · filed 2020-02-19
2018-03-31$1.16
10-K · filed 2020-02-19
-$0.42
derived: net income ÷ weighted average shares · filed 2020-02-19
$0.11
derived: net income ÷ weighted average shares · filed 2020-02-19
$1.07
derived: net income ÷ weighted average shares · filed 2020-02-19
2017-12-31-$1.58
8-K · filed 2019-10-24
-$1.05
derived: net income ÷ weighted average shares · filed 2020-02-19
-$0.09
derived: net income ÷ weighted average shares · filed 2020-02-19
-$0.19
10-K · filed 2020-02-19
2017-09-30$0.53
8-K · filed 2019-10-24
$1.48
derived: net income ÷ weighted average shares · filed 2018-11-06
$1.37
10-Q · filed 2018-11-06
$2.10
derived: net income ÷ weighted average shares · filed 2019-10-24
2017-06-30$0.95
8-K · filed 2019-10-24
$0.85
10-Q · filed 2018-07-25
$1.58
derived: net income ÷ weighted average shares · filed 2019-10-24
$2.31
derived: net income ÷ weighted average shares · filed 2019-10-24
2017-03-31-$0.10
8-K · filed 2019-10-24
$0.62
derived: net income ÷ weighted average shares · filed 2019-10-24
$1.36
derived: net income ÷ weighted average shares · filed 2019-10-24
$2.06
derived: net income ÷ weighted average shares · filed 2019-10-24
2016-12-31$0.73
10-K · filed 2018-02-20
$1.46
derived: net income ÷ weighted average shares · filed 2019-10-24
$2.16
derived: net income ÷ weighted average shares · filed 2019-10-24
$2.58
8-K · filed 2019-10-24
2016-09-30$0.73
10-K · filed 2018-02-20
$1.44
derived: net income ÷ weighted average shares · filed 2017-10-27
$1.85
10-Q · filed 2017-10-27
$2.30
derived: net income ÷ weighted average shares · filed 2018-02-20
2016-06-30$0.71
10-K · filed 2018-02-20
$1.12
10-Q · filed 2017-07-28
$1.57
derived: net income ÷ weighted average shares · filed 2018-02-20
$2.32
derived: net income ÷ weighted average shares · filed 2018-02-20
2016-03-31$0.41
10-K · filed 2018-02-20
$0.86
derived: net income ÷ weighted average shares · filed 2018-02-20
$1.61
derived: net income ÷ weighted average shares · filed 2018-02-20
$2.18
derived: net income ÷ weighted average shares · filed 2018-02-20
2015-12-31$0.45
10-K · filed 2017-02-21
$1.20
derived: net income ÷ weighted average shares · filed 2018-02-20
$1.76
derived: net income ÷ weighted average shares · filed 2018-02-20
$2.26
10-K · filed 2018-02-20
2015-09-30$0.75
10-K · filed 2017-02-21
$1.31
derived: net income ÷ weighted average shares · filed 2017-02-21
$1.81
10-Q · filed 2016-10-28
$2.21
derived: net income ÷ weighted average shares · filed 2017-02-21
2015-06-30$0.56
10-K · filed 2017-02-21
$1.06
10-Q · filed 2016-07-28
$1.46
derived: net income ÷ weighted average shares · filed 2017-02-21
$1.93
derived: net income ÷ weighted average shares · filed 2017-02-21
2015-03-31$0.50
10-K · filed 2017-02-21
$0.90
derived: net income ÷ weighted average shares · filed 2017-02-21
$1.36
derived: net income ÷ weighted average shares · filed 2017-02-21
$2.04
derived: net income ÷ weighted average shares · filed 2017-02-21
2014-12-31$0.40
10-K · filed 2016-02-19
$0.87
derived: net income ÷ weighted average shares · filed 2017-02-21
$1.55
derived: net income ÷ weighted average shares · filed 2017-02-21
$2.23
10-K · filed 2017-02-21
2014-09-30$0.47
10-K · filed 2016-02-19
$1.15
derived: net income ÷ weighted average shares · filed 2016-02-19
$1.82
10-Q · filed 2015-10-30
$2.50
derived: net income ÷ weighted average shares · filed 2016-02-19
2014-06-30$0.68
10-K · filed 2016-02-19
$1.36
10-Q · filed 2015-07-30
$2.03
derived: net income ÷ weighted average shares · filed 2016-02-19
$3.14
derived: net income ÷ weighted average shares · filed 2016-02-19
2014-03-31$0.68
10-K · filed 2016-02-19
$1.35
derived: net income ÷ weighted average shares · filed 2016-02-19
$2.46
derived: net income ÷ weighted average shares · filed 2016-02-19
$3.58
derived: net income ÷ weighted average shares · filed 2016-02-19
2013-12-31$0.67
10-K · filed 2015-02-19
$1.78
derived: net income ÷ weighted average shares · filed 2016-02-19
$2.90
derived: net income ÷ weighted average shares · filed 2016-02-19
$4.32
10-K · filed 2016-02-19
2013-09-30$1.11
10-K · filed 2015-02-19
$2.22
derived: net income ÷ weighted average shares · filed 2015-02-19
$3.64
10-Q · filed 2014-10-29
2013-06-30$1.11
10-K · filed 2015-02-19
$2.53
10-Q · filed 2014-07-28
2013-03-31$1.42
10-K · filed 2015-02-19
2012-12-31$0.74
10-K · filed 2014-02-19
$3.66
10-K · filed 2015-02-19
2012-09-30$1.18
10-K · filed 2014-02-19
$2.92
10-Q · filed 2013-10-30
2012-06-30$0.83
10-K · filed 2014-02-19
$1.73
10-Q · filed 2013-07-26
2012-03-31$0.91
10-K · filed 2014-02-19
2011-12-31$3.90
10-K · filed 2014-02-19
2010-12-31$4.58
10-K · filed 2013-02-21
2009-12-31$3.94
10-K · filed 2012-02-24
2008-12-31-$1.89
10-K · filed 2011-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Akari Therapeutics Plc (AKTX)$1,527.991B-47,921.42
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94